Xue-jiao Leng

Comparative metabolites in plasma and urine of normal and type 2 diabetic rats after oral administration of the traditional Chinese scutellaria-coptis herb couple by ultra performance liquid chromatography-tandem mass spectrometry.

S. Su, J. Duan, Jianming Guo, 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Challenges for the development of mutant isocitrate dehydrogenases 1 inhibitors to treat glioma.

P. Zhang, Shaopeng Yu, J Wu, 2023, European journal of medicinal chemistry.

Identification of the metabolites of myricitrin produced by human intestinal bacteria in vitro using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry

S. Su, J. Duan, Jianming Guo, 2014, Expert opinion on drug metabolism & toxicology.

Design and synthesis of selective FLT3 inhibitors via exploration of back pocket II.

Nan Li, Nianguang Li, Weichen Dai, 2023, Future Medicinal Chemistry.

Synthesis and biological evaluation of 4-(4-aminophenyl)-6-methylisoxazolo[3,4-b] pyridin-3-amine covalent inhibitors as potential agents for the treatment of acute myeloid leukemia.

Yu Cao, H. Zhou, Nianguang Li, 2022, Bioorganic & medicinal chemistry.

Natural products as potential lead compounds to develop new antiviral drugs over the past decade.

Jin Yang, J Wu, Nianyu Li, 2023, European journal of medicinal chemistry.

Research strategies of small molecules as chemotherapeutics to overcome multiple myeloma resistance.

Xin Xue, Ning Ding, Xue-jiao Leng, 2024, European journal of medicinal chemistry.

Exploring drug repositioning possibilities of kinase inhibitors via molecular simulation.

Jing-Jing Wang, Ning Ding, Zhen Tong, 2024, Molecular informatics.